Elastography Imaging Market By Product Type (Ultrasound Elastography [Shear Wave, Strain], Magnetic Resonance Elastography); By Application (Liver Disease, Breast Cancer, Prostate Cancer, Thyroid Nodules, Musculoskeletal Disorders, Others); By End User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Elastography Imaging Market valued at USD 3.24 billion in 2024 and projected to reach USD 6.91 billion by 2030 at 13.4% CAGR, driven by ultrasound technology, liver diagnostics, market growth, medical imaging devices, advanced healthcare, tissue elasticity measurement, as reported by Strategic Market Research.

 

Elastography imaging, an advanced non-invasive imaging modality, quantifies tissue stiffness and elasticity to facilitate early diagnosis and characterization of various pathological conditions — particularly cancers, liver fibrosis, and musculoskeletal disorders. By enhancing the diagnostic specificity and sensitivity of conventional ultrasound and magnetic resonance imaging (MRI), elastography has emerged as a critical tool in precision medicine. Its strategic relevance is further amplified by the global burden of chronic liver diseases, rising cancer incidence, and the increasing demand for minimally invasive diagnostic technologies.

 

This growth trajectory is driven by several synergistic macroeconomic and clinical forces, including:

• Technological evolution in real-time shear wave and strain imaging modalities

• Favorable reimbursement policies in North America and parts of Europe for liver and breast cancer diagnostics

• Escalating prevalence of liver cirrhosis, NASH, and cancer in APAC and Latin America

• Shift towards value-based imaging in outpatient and ambulatory settings

Moreover, the rising adoption of point-of-care ultrasound (POCUS) with elastographic capabilities is expanding the addressable market across primary care and emergency settings.

 

Key stakeholders shaping this market include:

• Original Equipment Manufacturers (OEMs) such as GE HealthCare, Siemens Healthineers, and Canon Medical Systems, who drive product development and innovation

• Hospitals, diagnostic imaging centers, and outpatient facilities as primary end users

• Government bodies and public health agencies funding early detection and screening programs

• Private equity and institutional investors, increasingly acquiring diagnostic imaging assets in high-growth geographies

• AI and digital health startups focusing on software enhancement and image analysis automation

The competitive landscape is transitioning from hardware-focused dominance to integrated platforms that combine AI-driven analytics, elastographic overlays, and remote diagnostics — reshaping how providers diagnose and monitor complex diseases.

 

Comprehensive Market Snapshot

The Global Elastography Imaging Market is valued at USD 3.24 billion in 2024 and is projected to reach USD 6.91 billion by 2030, expanding at a CAGR of 13.4%.

• USA leads the global landscape with a 38.3% share, translating to USD 1.24 Billion in 2024, supported by advanced imaging infrastructure, strong clinical adoption of ultrasound elastography, and a projected CAGR of 12.3% driving the market to approximately USD 2.49 Billion by 2030.

• Asia Pacific (APAC) emerges as the fastest-growing region with a 15.9% CAGR, starting from USD 1.17 Billion in 2024 with a 36.0% share, fueled by expanding healthcare access, rising liver disease prevalence, and increasing adoption of cost-effective imaging technologies.

• Europe holds a steady position with a 24.9% share, equating to USD 0.81 Billion in 2024, progressing at a CAGR of 11.2% to reach nearly USD 1.53 Billion by 2030, supported by structured diagnostic pathways and growing outpatient imaging demand.

 

Regional Insights

• USA (North America) accounted for the largest market share of 38.3% in 2024, supported by advanced imaging infrastructure and strong adoption of ultrasound-based diagnostics.

• Asia Pacific (APAC) is expected to expand at the fastest CAGR of 15.9% during 2024–2030, driven by rapid healthcare expansion and rising liver disease burden.

 

By Product Type

• Ultrasound Elastography dominates with a 62.0% share, accounting for USD 2.01 Billion in 2024, driven by its portability, cost-efficiency, and real-time diagnostic capabilities, especially in liver and breast imaging.

• Magnetic Resonance Elastography (MRE) represents the fastest-growing segment with a strong growth trajectory (estimated CAGR above 14%), valued at USD 1.23 Billion in 2024, gaining traction due to superior accuracy in deep tissue assessment and increased adoption in tertiary care centers.

• Shear Wave Elastography contributes significantly within ultrasound-based systems at USD 1.13 Billion, supported by its quantitative measurement precision.

• Strain Elastography holds a notable share of USD 0.88 Billion, benefiting from its integration into standard ultrasound workflows and broader accessibility.

 

By Application

• Liver Disease Diagnosis leads with a 40.0% share, reaching USD 1.30 Billion in 2024, driven by the growing global burden of chronic liver conditions such as NASH and hepatitis, alongside increasing screening initiatives.

• Breast Cancer Diagnosis is the fastest-growing application, valued at USD 0.58 Billion in 2024 and expected to expand at a strong CAGR exceeding 14%, supported by early detection programs and integration with mammography and ultrasound imaging.

• Prostate Cancer Assessment accounts for USD 0.39 Billion, benefiting from increasing demand for non-invasive diagnostic alternatives.

• Thyroid Nodule Evaluation and Musculoskeletal Disorders each contribute USD 0.32 Billion, supported by rising diagnostic imaging utilization in endocrine and orthopedic conditions.

• Other applications, including pancreatic and vascular assessments, collectively represent USD 0.32 Billion, reflecting expanding clinical use cases.

 

By End User

• Hospitals hold the largest share at 52.0%, corresponding to USD 1.68 Billion in 2024, driven by access to high-end imaging systems, multidisciplinary care settings, and higher patient inflow requiring advanced diagnostics.

• Diagnostic Imaging Centers are the fastest-growing segment, valued at USD 0.81 Billion in 2024 and expanding at a robust CAGR above 14%, fueled by the shift toward outpatient diagnostics and increasing demand for cost-effective imaging services.

• Specialty Clinics contribute USD 0.42 Billion, supported by focused diagnostic services in oncology and endocrinology.

• Academic & Research Institutes account for USD 0.32 Billion, reflecting ongoing clinical research and technology validation activities.

 

Strategic Questions Driving the Evolution of the Global Elastography Imaging Market

1. What imaging modalities, technologies, and clinical applications are explicitly included within the Elastography Imaging Market, and which adjacent imaging techniques fall outside its scope?

2. How does the Elastography Imaging Market structurally differ from conventional ultrasound, MRI imaging, and other diagnostic imaging markets?

3. What is the current and projected market size of elastography imaging, and how is value distributed across ultrasound-based and MRI-based technologies?

4. How is revenue allocated between shear wave elastography, strain elastography, and magnetic resonance elastography, and how is this mix expected to evolve?

5. Which clinical applications (e.g., liver disease, breast cancer, prostate assessment) contribute the largest revenue share, and which are expanding the fastest?

6. Which technology segments generate higher margins due to advanced capabilities, rather than higher procedure volumes alone?

7. How does demand vary across early-stage screening, routine diagnostics, and advanced disease monitoring, and how does this influence modality selection?

8. How are elastography technologies being integrated into diagnostic pathways as first-line, adjunct, or confirmatory imaging tools?

9. What role do scan frequency, repeat diagnostics, and longitudinal monitoring play in driving utilization and revenue growth?

10. How are rising disease prevalence, screening programs, and diagnostic awareness shaping demand across elastography applications?

11. What technical, regulatory, or clinical validation challenges limit adoption across specific imaging modalities or healthcare settings?

12. How do pricing dynamics, reimbursement frameworks, and healthcare budgets impact adoption across ultrasound and MRI-based elastography systems?

13. How strong is the current innovation pipeline in elastography imaging, and which emerging technologies or AI integrations are likely to redefine diagnostic capabilities?

14. To what extent will technological advancements expand the addressable patient population versus intensifying competition among existing imaging providers?

15. How are improvements in imaging resolution, portability, and automation enhancing diagnostic accuracy and workflow efficiency?

16. How will equipment lifecycle, upgrade cycles, and technological obsolescence influence competitive dynamics across imaging vendors?

17. What role will cost-effective portable ultrasound systems play in expanding access and driving market penetration in emerging regions?

18. How are leading manufacturers positioning their product portfolios across premium MRI systems and portable ultrasound devices to capture diverse market segments?

19. Which geographic regions are expected to outperform global growth, and which applications or technologies are driving this regional expansion?

20. How should stakeholders prioritize investments across technologies, applications, and regions to maximize long-term growth and competitive advantage?

 

Segment-Level Insights and Market Structure

Elastography Imaging Market

The Elastography Imaging Market is organized across distinct technology modalities, clinical applications, and end-user environments, each reflecting differences in diagnostic depth, cost structure, and care delivery settings. These segments influence how value is created across the market, with variations driven by disease burden, imaging accessibility, and the increasing shift toward non-invasive diagnostic solutions.

 

Product Type Insights

Ultrasound Elastography

Ultrasound elastography represents the most widely adopted modality within the market, supported by its accessibility, relatively lower cost, and ability to deliver real-time tissue stiffness assessment. Its integration into conventional ultrasound systems enables clinicians to perform combined anatomical and functional imaging in a single session. This modality is particularly prevalent in liver and breast diagnostics, where rapid screening and follow-up evaluations are essential. From a market standpoint, ultrasound elastography forms the backbone of routine elastography usage, benefiting from portability and expanding deployment in outpatient and point-of-care settings.

Shear Wave Elastography

Shear wave elastography is a technologically advanced subset of ultrasound-based imaging that provides quantitative and reproducible measurements of tissue elasticity. Its precision enhances diagnostic confidence, especially in liver fibrosis staging and oncology-related assessments. As clinical guidelines increasingly emphasize quantitative evaluation, this segment is gaining importance in facilities seeking standardized and operator-independent results. Its growth is closely tied to advancements in software algorithms and improved imaging consistency.

Strain Elastography

Strain elastography continues to maintain relevance due to its simplicity and compatibility with existing ultrasound platforms. It relies on relative tissue deformation, making it suitable for comparative assessments in applications such as breast and thyroid imaging. Although it is more operator-dependent than shear wave techniques, its affordability and ease of use support widespread adoption, particularly in resource-constrained environments. This segment contributes to market volume through its accessibility rather than technological complexity.

Magnetic Resonance Elastography (MRE)

Magnetic resonance elastography represents a premium segment characterized by high diagnostic accuracy and the ability to assess deeper organs with greater detail. It is primarily utilized in advanced clinical settings, including tertiary hospitals and specialized imaging centers. MRE is particularly valuable in complex liver disease evaluation and emerging neurological applications. While its adoption is limited by higher costs and infrastructure requirements, it plays a critical role in high-precision diagnostics and contributes significantly to market value on a per-procedure basis.

 

Application Insights

Liver Disease Diagnosis

Liver disease assessment remains the dominant application area, driven by the global rise in chronic liver conditions such as fatty liver disease and viral hepatitis. Elastography provides a non-invasive alternative to biopsy, enabling repeated monitoring of fibrosis progression and treatment response. Its clinical utility in early detection and disease staging has made it a standard component of hepatology workflows. This segment anchors overall market demand due to its large patient base and frequent diagnostic requirements.

Breast Cancer Diagnosis

Breast imaging is emerging as a rapidly expanding application, supported by the growing emphasis on early cancer detection and improved lesion characterization. Elastography enhances conventional imaging by differentiating benign and malignant tissues based on stiffness, reducing unnecessary biopsies. Its integration into routine screening and diagnostic protocols is increasing, particularly in urban healthcare systems with established imaging infrastructure.

Prostate Cancer Assessment

Elastography is gaining traction in prostate imaging as clinicians seek more accurate and less invasive diagnostic tools. It supports lesion detection and targeted biopsy guidance, improving diagnostic precision. Although still developing compared to other applications, this segment reflects growing interest in enhancing prostate cancer screening and management pathways.

Thyroid Nodule Evaluation

In thyroid imaging, elastography assists in distinguishing malignant nodules from benign ones, supporting clinical decision-making and reducing unnecessary surgical interventions. Its use is expanding alongside increased thyroid disorder screening, particularly in regions with high diagnostic awareness.

Musculoskeletal Disorders

Musculoskeletal applications focus on evaluating soft tissue stiffness in tendons, muscles, and ligaments. Elastography is used in sports medicine and rehabilitation to monitor injury and recovery. While smaller in market size, this segment demonstrates niche growth driven by specialized clinical needs.

Other Applications

Additional uses, including pancreatic assessment and vascular elasticity measurement, are gradually emerging as technology capabilities expand. These applications reflect the broader potential of elastography beyond traditional use cases and may contribute to long-term market diversification.

 

End User Insights

Hospitals

Hospitals represent the primary setting for elastography imaging, supported by their access to advanced diagnostic infrastructure and multidisciplinary expertise. They handle a wide range of cases, from routine screening to complex disease evaluation, often utilizing both ultrasound and MRI-based elastography systems. Their role in managing high patient volumes and advanced conditions positions them as the largest contributors to market demand.

Diagnostic Imaging Centers

Diagnostic imaging centers are becoming increasingly important as healthcare systems shift toward outpatient and specialized diagnostic services. These centers focus on efficiency and high patient throughput, often adopting ultrasound elastography systems due to their cost-effectiveness and versatility. Their expansion is particularly notable in urban and semi-urban regions where demand for accessible imaging services is rising.

Specialty Clinics

Specialty clinics, including hepatology, oncology, and endocrinology practices, utilize elastography for targeted diagnostic purposes. Their adoption is driven by the need for quick, non-invasive assessments within focused care pathways. This segment reflects the decentralization of diagnostic services into specialized care environments.

Academic & Research Institutes

Academic and research institutions play a key role in advancing elastography technologies and exploring new clinical applications. Their involvement in clinical trials and technology validation contributes to innovation and long-term market development. While smaller in commercial contribution, they are essential for shaping future adoption trends.

 

Segment Evolution Perspective

The Elastography Imaging Market is transitioning from a predominantly ultrasound-based diagnostic approach toward a more diversified ecosystem that includes advanced MRI applications and quantitative imaging techniques. Established modalities continue to support large-scale screening and routine diagnostics, while emerging technologies are enhancing precision and expanding clinical use cases.

At the same time, the shift toward outpatient care, portable imaging solutions, and digital integration is influencing how services are delivered. As healthcare systems prioritize early detection, non-invasive diagnostics, and cost efficiency, the balance between accessibility and technological sophistication will define how value is distributed across segments in the coming years.

 

Market Segmentation And Forecast Scope

The global elastography imaging market (2024–2030) can be comprehensively segmented based on Product Type, Application, End User, and Region. This segmentation reflects both clinical utility and commercial focus, with emerging sub-segments gaining traction through innovation and targeted diagnostics.

By Product Type

• Ultrasound Elastography

  • Shear Wave Elastography

  • Strain Elastography

• Magnetic Resonance Elastography (MRE)

Ultrasound elastography dominates the market, owing to its cost-effectiveness, portability, and real-time imaging capabilities. It is increasingly integrated into portable and handheld ultrasound systems for broader point-of-care access.

Magnetic Resonance Elastography, though costlier, is gaining ground in tertiary-care centers due to its superior accuracy in evaluating deeper tissues such as liver, pancreas, and brain.

 

By Application

• Liver Disease Diagnosis

• Breast Cancer Diagnosis

• Prostate Cancer Assessment

• Thyroid Nodule Evaluation

• Musculoskeletal Disorders

• Others (e.g., pancreatic lesions, vascular elasticity)

Liver disease diagnosis remains the largest application segment, driven by the increasing prevalence of non-alcoholic steatohepatitis (NASH) and hepatitis B/C globally. However, the breast cancer diagnosis segment is emerging as the fastest-growing, aided by growing awareness and integration of elastography with routine mammography/ultrasound workflows.

 

By End User

• Hospitals

• Diagnostic Imaging Centers

• Specialty Clinics

• Academic & Research Institutes

Hospitals account for the lion’s share of usage, given their access to high-end MRE and integrated ultrasound systems. Meanwhile, diagnostic imaging centers are rapidly increasing their adoption, especially in urban Asia and Europe, where outpatient diagnostics are expanding.

 

By Region

• North America

• Europe

• Asia Pacific

• LAMEA (Latin America, Middle East, and Africa)

 

While North America remains the most mature market, Asia Pacific is projected to be the fastest-growing region, supported by:

• Increasing liver cancer incidence in China and Southeast Asia

• Expanding imaging infrastructure in India and South Korea

• Strategic public-private partnerships and favorable import policies

Strategically, companies are increasingly focusing on dual-modality systems that combine elastography with AI-driven diagnostics and cloud-based data sharing to appeal to research centers and private imaging labs.

 

Market Trends And Innovation Landscape

The elastography imaging market is undergoing rapid transformation, fueled by advances in imaging technology, AI integration, and clinical application diversification. Innovations are not only enhancing diagnostic precision but also making elastography more accessible across varied healthcare settings.

Technology Convergence: AI Meets Elastography

One of the most prominent trends is the integration of artificial intelligence and machine learning in elastographic imaging. AI algorithms are now being embedded into ultrasound consoles and MRI platforms to:

• Automate stiffness quantification and fibrosis scoring

• Differentiate benign vs. malignant lesions with higher accuracy

• Provide real-time image quality assessment and feedback

For example, GE HealthCare and Canon Medical have launched next-gen ultrasound platforms with built-in AI-assisted elastography that significantly reduces operator variability.

 

Hardware Evolution and Portability

Manufacturers are increasingly shifting from bulky, cart-based systems to handheld and portable devices equipped with shear wave elastography. These compact platforms enable broader point-of-care use — particularly in:

• Primary care settings

• Emergency departments

• Remote and underserved regions

This shift supports the trend of decentralized imaging — bringing diagnostic capabilities closer to the patient.

 

Cloud Connectivity and Teleradiology Integration

Elastography devices are now being equipped with cloud-syncing capabilities, allowing seamless transfer of imaging data for:

• Remote specialist interpretation

• Multidisciplinary collaboration

• AI-assisted second opinion engines

Philips and Siemens Healthineers have both launched platforms that integrate elastography data into centralized diagnostic clouds, improving interdepartmental workflows.

 

Modality Hybridization

There is growing interest in dual-modality systems, where elastography is combined with:

• Contrast-enhanced ultrasound (CEUS)

• 3D ultrasound

• MRI/PET integration

These innovations offer richer tissue characterization and are being increasingly adopted in oncology diagnostics.

 

Partnerships and Academic Collaborations

Leading OEMs are partnering with universities, CROs, and AI startups to accelerate:

• Real-world validation of elastography biomarkers

• Development of AI-based fibrosis grading tools

• Cross-specialty clinical trials (e.g., liver, prostate, breast)

For instance, Siemens Healthineers has formed a multi-year partnership with academic research hubs in Europe to validate elastographic imaging biomarkers in chronic liver disease and musculoskeletal health.

 

R&D Pipeline: What’s Coming Next?

Several companies are developing automated quantification software, wearable ultrasound patches, and robotic elastography systems for minimally invasive procedures. These could radically reshape how elastography is used in interventional radiology and intraoperative settings.

Experts predict that within the next five years, AI-enhanced elastography will become a standard diagnostic protocol for liver disease staging and tumor surveillance in many healthcare systems.

 

Competitive Intelligence And Benchmarking

The global elastography imaging market is moderately consolidated, with a mix of multinational conglomerates and specialized imaging companies competing across ultrasound and MRI-based modalities. The competition is not solely on hardware but increasingly on workflow integration, AI capabilities, and cross-specialty adaptability .

GE HealthCare

GE HealthCare is a dominant player in ultrasound-based elastography, offering both shear wave and strain imaging within its premium and mid-tier ultrasound systems. The company’s strategic edge lies in its:

• Integration of AI-powered lesion detection

• Expanding handheld ultrasound portfolio

• Global service network across North America, Europe, and emerging Asia Pacific markets

Its LOGIQ series has been frequently updated to include liver stiffness quantification and breast elastography , offering excellent versatility in outpatient diagnostics.

 

Siemens Healthineers

Siemens remains a technological leader in both ultrasound and MRI elastography. It leverages its flagship Acuson and Magnetom platforms to deliver integrated stiffness mapping for liver, prostate, and musculoskeletal evaluations. Its competitive strategy revolves around:

• Cutting-edge 3D shear wave algorithms

• Collaborations with academic and cancer research centers

• Strong regulatory and reimbursement expertise across Europe and the U.S.

Siemens' innovations in MRI elastography have set benchmarks for quantitative liver fibrosis scoring.

 

Canon Medical Systems

Canon offers high-resolution ultrasound elastography systems that appeal to hospitals and high-throughput diagnostic imaging centers. Known for:

• User-friendly UI/UX interfaces

• Deep penetration imaging (e.g., for abdominal and prostate)

• Aggressive pricing strategies in Asia and Latin America

Canon’s recent product lines are increasingly being integrated with AI-assisted workflow enhancements to support liver cancer surveillance.

 

Philips Healthcare

Philips focuses on premium elastography solutions embedded with radiology PACS systems and AI diagnostics. The company’s strength lies in:

• Interoperability across elastography , CT, and MRI

• Focus on telehealth and teleradiology ecosystems

• Broad global reach with installed base in over 100 countries

Philips is also investing in elastography for musculoskeletal and vascular imaging applications — expanding beyond traditional liver and oncology use cases.

 

Esaote

An emerging player, especially in Europe and Latin America, Esaote targets niche markets through:

• Compact and mobile ultrasound elastography systems

• Attractive pricing for small clinics and research use

• Growing involvement in sports medicine and rheumatology applications

 

Resoundant Inc.

A pioneer in MR elastography software, Resoundant’s proprietary MRE technology is licensed to many OEMs and used in top-tier academic centers. It offers:

• Non-invasive liver stiffness quantification via MRI

• Applications expanding into brain and cardiac MRE

Their partnership with Mayo Clinic has driven research-led adoption of MRE in chronic liver and neurodegenerative disease diagnostics.

 

Hologic, Inc.

While primarily a leader in women’s health imaging, Hologic has begun to integrate elastography within its breast ultrasound platforms. Their strategic vision is:

• To elevate cancer screening accuracy

• To complement their existing breast biopsy and mammography solutions

The future competitive edge will lie in cross-specialty elastography tools integrated with radiology software ecosystems, AI-based auto-reporting, and cloud-based collaborative platforms — rather than standalone imaging features.

 

Regional Landscape And Adoption Outlook

The adoption of elastography imaging varies significantly across regions, shaped by healthcare infrastructure maturity, disease epidemiology, reimbursement policies, and availability of trained professionals. While North America and Europe remain innovation hubs, Asia Pacific and parts of LAMEA are driving the next wave of volume growth.

North America

North America holds the largest share in the global elastography imaging market, supported by:

• High prevalence of chronic liver disease (especially NAFLD and hepatitis C)

• Widespread deployment of advanced imaging systems

• Well-established reimbursement pathways, especially in the U.S. under CMS guidelines

The United States leads the global market due to aggressive adoption by hospitals, large imaging centers, and research institutions. Canada also contributes significantly, benefiting from centralized diagnostic imaging funding and provincial liver screening programs.

Example: The American Association for the Study of Liver Diseases (AASLD) recommends elastography as a non-invasive method for fibrosis staging, accelerating institutional adoption.

 

Europe

Europe follows closely behind North America, driven by:

• Standardized imaging protocols and supportive national guidelines (e.g., EASL)

• Rapid uptake of breast and thyroid elastography in France, Germany, and the UK

• Strong OEM presence, including Siemens, Esaote, and Philips

Countries like Germany and France lead in MRI elastography deployment, whereas Italy, Spain, and Nordic nations are growing users of shear wave technology in oncology and musculoskeletal care.

Reimbursement for elastography procedures is more consistent across Western Europe than in emerging Eastern European markets, which still rely heavily on conventional ultrasound.

 

Asia Pacific

Asia Pacific is the fastest-growing regional market, expanding at a projected CAGR exceeding 16% due to:

• High burden of hepatitis B/C and liver cancer, especially in China, India, and Southeast Asia

• Government initiatives for early disease detection (e.g., China’s Healthy China 2030 agenda)

• Expansion of private diagnostic imaging chains across urban centers

China is the regional heavyweight, with hospitals rapidly upgrading to shear wave-capable ultrasound systems. India, while still cost-sensitive, is seeing elastography adoption among top-tier hospitals and metro-based diagnostic labs.

Japan and South Korea are mature imaging markets where real-time elastography is already embedded into routine workflows, particularly in hepatology and oncology.

 

LAMEA (Latin America, Middle East & Africa)

This region presents a mixed adoption landscape, with growing demand tempered by infrastructure gaps and limited reimbursement.

• Brazil and Mexico are the most advanced in Latin America, showing demand for liver fibrosis and prostate cancer imaging via ultrasound elastography .

• In the Middle East, especially UAE and Saudi Arabia, private hospitals are investing in elastography as part of broader diagnostic suite upgrades.

• In Africa, adoption is mostly restricted to academic hospitals in South Africa, Egypt, and Nigeria, where donor-funded programs or NGO collaborations drive limited access.

 

End-User Dynamics And Use Case

The adoption of elastography imaging varies significantly across healthcare settings, largely influenced by infrastructure, operator training, diagnostic demand, and procedural throughput. Each end-user category plays a distinct role in expanding the global footprint of elastographic modalities, whether through routine screening, advanced diagnostics, or research-oriented applications.

Hospitals

Hospitals are the primary end users, accounting for over 50% of global market revenue. Their adoption is driven by:

• Availability of capital-intensive systems (e.g., MRE-capable MRI, high-end ultrasound platforms)

• Access to multi-specialty departments ( hepatology, oncology, radiology)

• Integration into inpatient and emergency workflows

Tertiary hospitals often deploy elastography for both routine screening (e.g., liver fibrosis staging) and advanced assessments (e.g., tumor stiffness characterization).

 

Diagnostic Imaging Centers

Diagnostic imaging centers are rapidly increasing their adoption due to:

• Demand for outpatient-based liver and breast cancer screening

• Faster return-on-investment with high patient volume

• Competitive differentiation by offering AI-assisted elastography services

These centers often opt for mid-tier ultrasound systems with shear wave elastography for cost-effectiveness and versatility.

 

Specialty Clinics

Specialty clinics, especially in gastroenterology, endocrinology, and oncology, are beginning to adopt portable ultrasound systems with integrated elastography. The focus is typically on:

• Thyroid nodules, prostate evaluation, or breast lump differentiation

• Immediate, point-of-care diagnosis without referral delays

• Private-pay models or corporate screening programs

 

Academic & Research Institutes

These institutions are critical for:

• Clinical validation of new elastography algorithms

• Longitudinal studies on disease progression (e.g., fibrosis staging, musculoskeletal degeneration)

• Training and education of radiologists and sonographers

Many global OEMs partner with such institutes to evaluate AI-based image enhancement, quantitative stiffness thresholds, and new anatomical applications.

 

Use Case Highlight

“A tertiary care hospital in Seoul, South Korea, integrated real-time shear wave elastography into its liver clinic workflow for patients with hepatitis B and NASH. Over 12 months, the center reduced the need for liver biopsies by 42%, enhanced staging accuracy in 87% of chronic liver disease cases, and shortened time-to-treatment initiation by 23%. The team noted that the reproducibility and quantitative output of elastography allowed for better multidisciplinary decision-making and improved patient compliance.”

This example underscores the procedural value of elastography — not just in diagnosis but in streamlining clinical pathways, reducing invasive interventions, and driving evidence-based care.

 

Recent Developments + Opportunities & Restraints

Recent Developments (2023–2025)

• Canon Medical launched its new Aplio i800 ultrasound system in early 2024, featuring advanced shear wave elastography and AI-assisted liver stiffness measurement tailored for fatty liver and cirrhosis screening.

• Philips partnered with the Mayo Clinic in 2023 to integrate its elastography modules with cloud-based diagnostic platforms, enabling remote reading and collaboration for liver and oncology evaluations.

• Siemens Healthineers received CE approval in mid-2024 for its next-gen 3D elastography platform embedded within Acuson Sequoia systems, enhancing precision in breast and thyroid lesion assessments.

• Esaote expanded its MyLab X9 product line with elastography capabilities for musculoskeletal and sports medicine use, targeting European outpatient clinics and private practices.

• Resoundant and GE HealthCare announced a research collaboration to validate brain stiffness biomarkers via MRI elastography in neurodegenerative diseases like Alzheimer’s.

 

Opportunities

• Expansion in Emerging Economies : Rapid diagnostic infrastructure growth in countries like India, Vietnam, Brazil, and Egypt creates demand for affordable and portable elastography devices — especially in liver disease surveillance.

• AI and Workflow Automation : The integration of automated fibrosis grading, lesion segmentation, and remote reporting is attracting outpatient diagnostic chains and teleradiology providers looking to scale efficiently.

• Non-Invasive Cancer Screening Programs : With global emphasis on early detection, breast, prostate, and thyroid elastography is gaining inclusion in government and corporate screening initiatives, opening doors for wider adoption.

 

Restraints

• High Equipment Cost and Maintenance : Advanced elastography -enabled MRI and premium ultrasound systems can be prohibitively expensive, limiting adoption in community hospitals and rural clinics, especially in LAMEA.

• Lack of Trained Operators and Interpretation Expertise : Elastography output, while rich in information, often requires specialized training for accurate interpretation — a challenge in under-resourced settings.

 

7.1. Report Coverage Table

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 3.24 Billion
Revenue Forecast in 2030	USD 6.91 Billion
Overall Growth Rate	CAGR of 13.4% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2019 – 2023
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Product Type, By Application, By End User, By Region
By Product Type	Ultrasound Elastography, Magnetic Resonance Elastography
By Application	Liver Disease, Breast Cancer, Prostate Cancer, Thyroid Nodules, Musculoskeletal Disorders, Others
By End User	Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Academic & Research Institutes
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, Germany, U.K., France, China, Japan, India, Brazil, South Korea, GCC
Market Drivers	- AI-integrated diagnostic tools - Rising liver and cancer burden - Demand for non-invasive alternatives
Customization Option	Available upon request